Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IAT-TOP: Intra-arterial Alteplase for Posterior Circulation Stroke
NCT05897554Completed
- Sponsor
- Xuanwu Hospital
- Start
- Aug 2023
- Primary completion
- Mar 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in Posterior Circulation Stroke (PCS) (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Rate of modified Rankin Scale score of 0-2 at 90 days. Started Aug 2023; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
Posterior Circulation Stroke (PCS)
Beyond the preview
Go deeper on NCT05897554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897554.